688389 logo

Shenzhen Lifotronic Technology Co., Ltd. Stock Price

SHSE:688389 Community·CN¥5.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

688389 Share Price Performance

CN¥13.78
-2.25 (-14.04%)
CN¥13.78
-2.25 (-14.04%)
Price CN¥13.78

688389 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with excellent balance sheet and pays a dividend.

0 Risks
3 Rewards

Shenzhen Lifotronic Technology Co., Ltd. Key Details

CN¥1.1b

Revenue

CN¥382.9m

Cost of Revenue

CN¥671.2m

Gross Profit

CN¥420.2m

Other Expenses

CN¥251.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 23, 2026
0.59
63.68%
23.81%
16.3%
View Full Analysis

About 688389

Founded
2008
Employees
1658
CEO
Ming Long Hu
WebsiteView website
www.lifotronic.com

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well as offers E-training services. Further, it offers medical beauty related products. Additionally, the company exports its products. Shenzhen Lifotronic Technology Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.

Recent 688389 News & Updates

Recent updates

No updates